WallStSmart
PRTA

Prothena Corporation plc

NASDAQ: PRTA · HEALTHCARE · BIOTECHNOLOGY

$10.87
-5.56% today

Updated 2026-04-29

Market cap
$619.62M
P/E ratio
P/S ratio
63.98x
EPS (TTM)
$-4.53
Dividend yield
52W range
$4 – $12
Volume
0.5M

Prothena Corporation plc (PRTA) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-1.8%
Last 4 quarters
Revenue YoY growth
-99.0%
Most recent quarter
EPS YoY growth
+57.7%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-0.2%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-0.8%
2025-11-10
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-12$-0.46+22.3%$8.93$8.96+0.3%
2025-11-10$-0.67-24.1%$10.56$10.48-0.8%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.59$-0.46+22.3%$21000.00-99.0%
2025-09-30$-0.54$-0.67-24.1%$2.42M+149.0%
2025-06-30$-1.79$-1.73+3.4%$4.42M-96.7%
2025-03-31$-1.03$-1.12-8.7%$2.83M+5556.0%
2024-12-31$-1.04$-1.08-3.8%$2.12M+571.8%
2024-09-30$-1.18$-1.10+6.8%$970000.00-98.9%
2024-06-30$-1.05$1.22+216.2%$132.01M+3184.7%
2024-03-31$-1.20$-1.34-11.7%$50000.00-97.7%
2023-12-31$-1.22$-1.26-3.3%$316000.00
2023-09-30$-0.32$0.38+218.8%$84.87M
2023-06-30$-1.00$-1.03-3.0%$4.02M
2023-03-31$-0.94$-0.89+5.3%$2.17M

Frequently asked questions

Has Prothena Corporation plc beaten earnings estimates?
Prothena Corporation plc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -1.8% over the last 4 quarters.
How does PRTA stock react to earnings?
PRTA stock has moved an average of -0.2% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Prothena Corporation plc's revenue growth rate?
Prothena Corporation plc reported year-over-year revenue growth of -99.0% in its most recent quarter, with EPS growing +57.7% year-over-year.